Preclinical Target Validation Using Patient-derived Cells.

Autoria(s): Edwards, Aled M; Arrowsmith, Cheryl H; Bountra, Chas; Bunnage, Mark E; Feldmann, Marc; Knight, Julian C; Patel, Dhavalkumar D; Prinos, Panagiotis; Taylor, Michael D; Sundström, Michael; Barker, Phil; Barsyte, Dalia; Bengtson, Mario H; Bell, Cindy; Bowness, Paul; Boycott, Kym M; Buser-Doepner, Carolyn; Carpenter, Christopher L; Carr, Andrew J; Clark, Kirk; Das, Anuk M; Dhanak, Dashyant; Dirks, Peter; Ellis, James; Fantin, Valeria R; Flores, Christopher; Fon, Edward A; Frail, Donald E; Gileadi, Opher; O'Hagan, Ronan C; Howe, Trevor; Isaac, John T R; Jabado, Nada; Jakobsson, Per-Johan; Klareskog, Lars; Knapp, Stefan; Lee, Wen Hwa; Lima-Fernandes, Evelyne; Lundberg, Ingrid E; Marshall, John; Massirer, Katlin B; MacKenzie, Alex E; Maruyama, Tetsuyuki; Mueller-Fahrnow, Anke; Muthuswamy, Senthil; Nanchahal, Jagdeep; O'Brien, Catherine; Oppermann, Udo; Ostermann, Nils; Petrecca, Kevin; Pollock, Bruce G; Poupon, Viviane; Prinjha, Rab K; Rosenberg, Saul H; Rouleau, Guy; Skingle, Malcolm; Slutsky, Arthur S; Smith, Garth A M; Verhelle, Dominique; Widmer, Hans; Young, L Trevor
Contribuinte(s)

UNIVERSIDADE DE ESTADUAL DE CAMPINAS
Data(s)

01/03/2015

27/11/2015

27/11/2015
Resumo

The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.

14

149-50
Identificador

Nature Reviews. Drug Discovery. v. 14, n. 3, p. 149-50, 2015-Mar.

1474-1784

10.1038/nrd4565

http://www.ncbi.nlm.nih.gov/pubmed/25722227

http://repositorio.unicamp.br/jspui/handle/REPOSIP/202168

25722227
Idioma(s)

eng
Relação

Nature Reviews. Drug Discovery

Nat Rev Drug Discov
Direitos

fechado
Fonte

PubMed
Tipo

Artigo de periódico
Acesso ao item digital